Effect of timolol on the diurnal intraocular pressure in exfoliation and primary open-angle glaucoma

Arch Ophthalmol. 1997 Aug;115(8):975-9. doi: 10.1001/archopht.1997.01100160145002.

Abstract

Objective: To describe and compare the diurnal intraocular pressure (IOP) variation in patients with exfoliation glaucoma (EXG) and primary open-angle glaucoma (POAG) who were treated with a solution of timolol maleate (0.5%) twice daily.

Design: Consecutive Greek patients who were newly diagnosed as having EXG or POAG were prospectively investigated; they underwent 24-hour diurnal IOP measurements first without therapy and then 6 months afterward while they were being treated with timolol maleate (0.5%). After matching for age, 38 pairs of patients with these 2 types of glaucoma were compared.

Results: Untreated patients with EXG had significantly higher IOP values for all time points assessed and a greater mean range of IOPs (11.8 mm Hg for EXG vs 7.6 mm Hg for POAG; P < or = .001). Following therapy with timolol maleate (0.5%) given twice daily, patients with EXG had higher IOP values for the measurements that were obtained at 6 and 10 AM, 10 PM, and 2 AM, a higher mean range of IOPs (7.0 mm Hg for EXG vs 5.6 mm Hg for POAG; P = .03), and a higher maximum IOP (mean, 24.9 mm Hg for EXG vs 20.9 mm Hg for POAG; P = .003). The reduction of the range of diurnal variation of IOP was more pronounced in patients with EXG than in patients with POAG (40% vs 26%; P = .04). Twenty-two (58%) of 38 patients with EXG and 20 (53%) of 38 patients with POAG had peak IOP values that were found outside office hours. Only 5 (13%) of the patients with EXG exhibited an IOP of 18 mm Hg or less at all time points compared with 12 (32%) of the patients with POAG (P = .05).

Conclusion: Despite a greater initial IOP reduction in the patients with EXG treated with timolol, a higher IOP and significant fluctuation in the diurnal curve of IOP during the time in which patients received therapy still characterized EXG from POAG.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use*
  • Aged
  • Circadian Rhythm / drug effects
  • Circadian Rhythm / physiology*
  • Exfoliation Syndrome / complications*
  • Female
  • Glaucoma, Open-Angle / drug therapy
  • Glaucoma, Open-Angle / etiology
  • Glaucoma, Open-Angle / physiopathology*
  • Humans
  • Intraocular Pressure / drug effects
  • Intraocular Pressure / physiology*
  • Male
  • Middle Aged
  • Ophthalmic Solutions
  • Prospective Studies
  • Timolol / therapeutic use*

Substances

  • Adrenergic beta-Antagonists
  • Ophthalmic Solutions
  • Timolol